MAP4K4 and Alzheimer disease: Unlike AD, where no functional studies using agents targeting MAP4K4 have been performed so far, MAP4K4 inhibition by the small molecule dual MAP4K4-GSK3 inhibitor kenpaullone was found to be motor-neuron protective in amyotrophic lateral sclerosis (ALS) (46).